Iksuda Therapeutics Enters License Agreement With University of Goettingen to Develop a New Generation of Antibody Drug Conjugates

Christel Deskins

Iksuda licenses novel protein-alkylating, tumour-activated pro-drug payload series to develop ADCs with enhanced therapeutic index Development to focus on targets associated with haematological and solid tumours Iksuda Therapeutics (Iksuda), the developer of enhanced, new-generation of Antibody Drug Conjugates (ADCs), today announces it has executed its option to secure exclusive, worldwide […]

Turning Point Brands Makes Strategic Investment in Wild Hempettes LLC and Enters Into a National Distribution Agreement

Christel Deskins

Turning Point Brands, Inc. (“TPB”) (NYSE: TPB), a manufacturer, marketer and distributor of branded consumer products with active ingredients, today announced that it has acquired a 20% stake in Wild Hempettes LLC (“Wild Hempettes”), a leading manufacturer of hemp cigarettes under the WildHemp™ and Hempettes™ brands, with options to […]

Todos Medical Enters into Exclusive Branding and Distribution Agreement with Melbourne Biotech …

Christel Deskins

NEW YORK, NY, REHOVOT, Israel, and SINGAPORE, Sept. 30, 2020 (GLOBE NEWSWIRE) — via NewMediaWire  — Todos Medical Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced that […]